Effectiveness and safety of prostatic artery embolization for the treatment of lower urinary tract symptoms from benign prostatic hyperplasia in men with concurrent localized prostate cancer.

To assess clinical effectiveness and safety of prostatic artery embolization (PAE) on lower urinary tract symptoms (LUTS) in the setting of localized prostate cancer (PCa).

This was a retrospective, single-center, institutional review board-approved study from December 2016 through June 2020 of 21 patients (median age 72, range 63-83) with moderate LUTS and localized PCa.